These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6985615)

  • 1. Gonadotropin-estradiol responses to a superactive luteinizing hormone-releasing hormone agonist in women.
    Casper RF; Sheehan KL; Yen SS
    J Clin Endocrinol Metab; 1980 Jan; 50(1):179-81. PubMed ID: 6985615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
    Sheehan KL; Casper RF; Yen SS
    Am J Obstet Gynecol; 1979 Nov; 135(6):759-63. PubMed ID: 386801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of pituitary gonadotropic function by an agonist of luteinizing hormone-releasing factor in the puerperium.
    Sheehan KL; Yen SS
    Am J Obstet Gynecol; 1979 Nov; 135(6):755-8. PubMed ID: 386800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase.
    Lemay A; Metha AE; Tolis G; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1983 May; 39(5):668-73. PubMed ID: 6404661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of luteinizing hormone (LH), follicle-stimulating hormone, and 17 beta-estradiol in response to D-Trp6-LH-releasing hormone during different phases of the menstrual cycle in normal women.
    Jaramillo CJ; Salgado AC; Perez-Infante V; Puente-Cueva M; Botella-Llusia J; Coy DH; Schally A
    Fertil Steril; 1978 Feb; 29(2):153-8. PubMed ID: 342285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of action of a new low-dosed combined oral contraceptive.
    Dericks-Tan JS; Schneider K; Taubert HD
    Arch Gynecol; 1980; 229(2):107-14. PubMed ID: 6768343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
    Wang CF; Lasley BL; Yen SS
    J Clin Endocrinol Metab; 1975 Jul; 41(1):41-3. PubMed ID: 1097463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women.
    Hall JE; Taylor AE; Martin KA; Rivier J; Schoenfeld DA; Crowley WF
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):6894-8. PubMed ID: 8041716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinizing hormone-releasing hormone agonist at different days after the midcycle luteinizing hormone surge.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1983 May; 39(5):661-7. PubMed ID: 6404660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of D-ser (TBU)6-LH-RH-EA10 upon gonadotropin release in normally cyclic women.
    Dericks-Tan JS; Hammer E; Taubert HD
    J Clin Endocrinol Metab; 1977 Sep; 45(3):597-600. PubMed ID: 332703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the (imBzl)D-His6, Des-Gly analog of GnRH on gonadotropin and estradiol secretion in normal women.
    DeFazio J; Lu JK; Vale W; Rivier J; Judd HL; Meldrum DR
    Endocr Res; 1984; 10(2):163-70. PubMed ID: 6437804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
    Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge.
    Leroy I; d'Acremont M; Brailly-Tabard S; Frydman R; de Mouzon J; Bouchard P
    Fertil Steril; 1994 Sep; 62(3):461-7. PubMed ID: 8062939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.
    Skarin G; Nillius SJ; Wide L
    Contraception; 1982 Jan; 25(1):31-9. PubMed ID: 6800690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control.
    Sheehan KL; Casper RF; Yen SS
    Science; 1982 Jan; 215(4529):170-2. PubMed ID: 6797068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.